Created in 1963 and based in L'Aigle, France, IMV Technologies is the World Leader in animal reproductive biotechnologies.
The Group has a dominant position in both the bovine and swine segments from gametes harvesting, analysis, packaging, freezing to insemination.
The IMV group also has a strong presence in aquaculture, equine and other markets.
The Group is committed to contribute to the preservation of the genetics of endangered species like the Great Panda in China.
Through its subsidiary Cryo Biosystems, IMV Technologies is also present since 1987 in the human reproduction and biobanking sector, applying its expertise in embryo vitrification and sperm freezing for medically assisted procreation procedures or cryo-preservation solutions for the biobanking of biological samples.
In 2021, the Group achieved a turnover of €135M and double-digit EBITDA ratio with a strong resilience in the COVID19 crisis environment.
Since its creation the Group has always experienced sustained growth and a high level of profitability.
Based in France, with subsidiaries in 9 countries (Brazil, China, India, Ireland, Netherlands, UK, United States, Spain, South Africa), and 3 representation offices (Germany, Italy, Russia) and an extensive network of distributors in more than 120 countries, IMV Technologies generates 88% of its turnover outside France.
The Group has seven production sites located in 5 countries (France, UK, Spain, Netherlands, China. The Group has over 650 employees, including 240 in France, 160 in China and 100 in the UK.
In addition to its organic development, IMV Technologies has been expanding its portfolio of activities and services through highly targeted acquisitions of either complementary businesses such as insemination endoscopy equipment (Herritech – 2015), ultrasound imaging (BCF & ECM - 2017), Swine Post Cervical AI (Tecnovet - 2020), technologies such as fish egg selection (GenetiRate - 2021) or manufacturing to strengthen the core business regionalization / localization such as the China Nelson Factory (2015).
The growth ambition is strong, aiming for a turnover of €200m within 5 years and a continuously improved high level of profitability.
To ensure its scalability and strengthen its process and organisation, the group has initiated different transformation programs in commercial efficiency, supply chain, quality and finance & IT systems.
To support the growth and these transformations, a specific focus is done on Lean to build the IMV Business System (IBS) and HR to set up a global HR strategy.
The Group started its fourth LBO in 2021 with Montagu Private Equity, that took over from Qualium Investissement, which was shareholder since 2014.
More than 80% of the Group's managers are shareholders and hold about 15% of the capital.
The Group's Management Committee has been chaired by Alain de Lambilly since January 2020.